IN2015DN00962A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00962A IN2015DN00962A IN962DEN2015A IN2015DN00962A IN 2015DN00962 A IN2015DN00962 A IN 2015DN00962A IN 962DEN2015 A IN962DEN2015 A IN 962DEN2015A IN 2015DN00962 A IN2015DN00962 A IN 2015DN00962A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- medicament
- description
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
The invention relates to a compound of formula (I) wherein A1, A2 and R1 to R6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12181247 | 2012-08-21 | ||
PCT/EP2013/067218 WO2014029722A1 (en) | 2012-08-21 | 2013-08-19 | Novel pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN00962A true IN2015DN00962A (en) | 2015-06-12 |
Family
ID=46851300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN962DEN2015 IN2015DN00962A (en) | 2012-08-21 | 2013-08-19 |
Country Status (24)
Country | Link |
---|---|
US (1) | US9409882B2 (en) |
EP (1) | EP2888244A1 (en) |
JP (1) | JP2015530997A (en) |
KR (1) | KR20150044947A (en) |
CN (1) | CN104583198A (en) |
AR (1) | AR092172A1 (en) |
AU (1) | AU2013305102A1 (en) |
BR (1) | BR112015003217A2 (en) |
CA (1) | CA2879796A1 (en) |
CL (1) | CL2015000354A1 (en) |
CO (1) | CO7200259A2 (en) |
CR (1) | CR20150073A (en) |
EA (1) | EA025166B1 (en) |
HK (1) | HK1206716A1 (en) |
IL (1) | IL237128A0 (en) |
IN (1) | IN2015DN00962A (en) |
MA (1) | MA37893A1 (en) |
MX (1) | MX2015002026A (en) |
PE (1) | PE20150995A1 (en) |
PH (1) | PH12015500262A1 (en) |
SG (1) | SG11201500900YA (en) |
TW (1) | TW201412728A (en) |
WO (1) | WO2014029722A1 (en) |
ZA (1) | ZA201500625B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20180404A (en) * | 2016-02-26 | 2018-10-18 | Hoffmann La Roche | NEW PIRROLIDINE DERIVATIVES |
TWI764976B (en) | 2017-01-24 | 2022-05-21 | 日商安斯泰來製藥股份有限公司 | Substituted phenyldifluoromethyl prolinamide compound |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9903610D0 (en) | 1999-10-06 | 1999-10-06 | Astra Ab | Novel compounds II |
US20090227555A2 (en) | 2005-01-06 | 2009-09-10 | Astrazeneca Ab | Novel Pyridine Compounds |
WO2007086001A2 (en) | 2006-01-24 | 2007-08-02 | Actelion Pharmaceuticals Ltd | Novel pyridine derivatives |
CA2686838C (en) * | 2007-05-09 | 2017-03-14 | Vertex Pharmaceuticals Incorporated | Modulators of cftr |
JP2011504898A (en) | 2007-11-30 | 2011-02-17 | エフ.ホフマン−ラ ロシュ アーゲー | Pyridine compounds |
ES2389042T3 (en) | 2008-03-06 | 2012-10-22 | Actelion Pharmaceuticals Ltd. | Pyridine compounds |
KR101320790B1 (en) * | 2009-04-20 | 2013-10-22 | 에프. 호프만-라 로슈 아게 | Proline derivatives as cathepsin inhibitors |
US8394834B2 (en) * | 2009-08-25 | 2013-03-12 | Hoffman-La Roche Inc. | Pyrrolidines as NK3 receptor antagonists |
WO2013049559A1 (en) | 2011-09-30 | 2013-04-04 | Endo Pharmaceuticals Inc. | Pyridine derivatives |
-
2013
- 2013-08-19 KR KR20157006927A patent/KR20150044947A/en not_active Application Discontinuation
- 2013-08-19 IN IN962DEN2015 patent/IN2015DN00962A/en unknown
- 2013-08-19 CN CN201380043572.1A patent/CN104583198A/en active Pending
- 2013-08-19 EP EP13750339.7A patent/EP2888244A1/en not_active Withdrawn
- 2013-08-19 MA MA37893A patent/MA37893A1/en unknown
- 2013-08-19 MX MX2015002026A patent/MX2015002026A/en unknown
- 2013-08-19 SG SG11201500900YA patent/SG11201500900YA/en unknown
- 2013-08-19 WO PCT/EP2013/067218 patent/WO2014029722A1/en active Application Filing
- 2013-08-19 JP JP2015527877A patent/JP2015530997A/en active Pending
- 2013-08-19 EA EA201590363A patent/EA025166B1/en not_active IP Right Cessation
- 2013-08-19 BR BR112015003217A patent/BR112015003217A2/en not_active Application Discontinuation
- 2013-08-19 PE PE2015000231A patent/PE20150995A1/en not_active Application Discontinuation
- 2013-08-19 CA CA2879796A patent/CA2879796A1/en not_active Abandoned
- 2013-08-19 TW TW102129708A patent/TW201412728A/en unknown
- 2013-08-19 AU AU2013305102A patent/AU2013305102A1/en not_active Abandoned
- 2013-08-20 AR ARP130102939A patent/AR092172A1/en unknown
-
2015
- 2015-01-27 ZA ZA2015/00625A patent/ZA201500625B/en unknown
- 2015-02-05 IL IL237128A patent/IL237128A0/en unknown
- 2015-02-06 PH PH12015500262A patent/PH12015500262A1/en unknown
- 2015-02-09 CO CO15025964A patent/CO7200259A2/en unknown
- 2015-02-11 CR CR20150073A patent/CR20150073A/en not_active Application Discontinuation
- 2015-02-16 CL CL2015000354A patent/CL2015000354A1/en unknown
- 2015-02-20 US US14/627,175 patent/US9409882B2/en not_active Expired - Fee Related
- 2015-07-27 HK HK15107145.2A patent/HK1206716A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE20150995A1 (en) | 2015-06-29 |
US20150307472A1 (en) | 2015-10-29 |
CO7200259A2 (en) | 2015-02-27 |
EA025166B1 (en) | 2016-11-30 |
CN104583198A (en) | 2015-04-29 |
MX2015002026A (en) | 2015-06-05 |
CL2015000354A1 (en) | 2015-10-23 |
CR20150073A (en) | 2015-03-13 |
SG11201500900YA (en) | 2015-03-30 |
PH12015500262A1 (en) | 2015-03-30 |
EA201590363A1 (en) | 2015-06-30 |
CA2879796A1 (en) | 2014-02-27 |
TW201412728A (en) | 2014-04-01 |
HK1206716A1 (en) | 2016-01-15 |
WO2014029722A1 (en) | 2014-02-27 |
AU2013305102A1 (en) | 2015-02-12 |
US9409882B2 (en) | 2016-08-09 |
MA37893A1 (en) | 2017-08-31 |
ZA201500625B (en) | 2016-08-31 |
KR20150044947A (en) | 2015-04-27 |
IL237128A0 (en) | 2015-03-31 |
AR092172A1 (en) | 2015-03-25 |
JP2015530997A (en) | 2015-10-29 |
EP2888244A1 (en) | 2015-07-01 |
BR112015003217A2 (en) | 2017-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501375A1 (en) | Pyridin-2-amides useful as cb2 agonists | |
PH12015501083B1 (en) | Novel pyridine derivatives | |
MY182328A (en) | Pyridine-2-amides useful as cb2 agonists | |
PH12015501843A1 (en) | Novel pyrazol derivatives | |
MY179412A (en) | Pyridine-2-amides useful as cb2 agonists | |
PH12015501933A1 (en) | Novel pyridine derivatives | |
MX349373B (en) | Novel pyrazine derivatives. | |
IN2015DN01061A (en) | ||
IN2014DN06104A (en) | ||
PH12015502471A1 (en) | Purine derivatives as cb2 receptor agonists | |
MX2014008141A (en) | Macrocyclic amides as protease inhibitors. | |
PH12016501865A1 (en) | Pyridine-2-amides useful as cb2 agonists | |
IN2014DN10669A (en) | ||
MX2015016766A (en) | Novel tetrazolone derivatives. | |
MX346090B (en) | Pyrrolidine derivatives used as cathepsin inhibitors. | |
MX2014008918A (en) | Novel pyrrolidine derivatives. | |
MY175703A (en) | Tablets with improved acceptance and good storage stability | |
IN2015DN00962A (en) | ||
MX351093B (en) | Novel azetidine derivatives. | |
UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
UA79010U (en) | Use of n-stearoylethanolamine as a substance with active antiinfluenzal action |